by mediaid pharmacy | Jan 29, 2026 | Blogs
Caboxen 20 mg and 80 mg (Cabozantinib) is an oral targeted therapy widely prescribed in oncology for the treatment of advanced and metastatic cancers. This article provides an expert, authoritative, and trust-driven overview of Caboxen capsules, including indications,...
by mediaid pharmacy | Jan 28, 2026 | Blogs
Modern medicine has introduced advanced targeted therapies that improve the quality of life for patients suffering from autoimmune and inflammatory diseases. One such trusted treatment option is Tofaxen 5 mg (Tofacitinib), widely prescribed for conditions like...
by mediaid pharmacy | Jan 28, 2026 | Blogs
Cancer care has advanced significantly with the introduction of targeted therapies and PARP inhibitors. One such trusted oncology medicine is Niranib 140 mg (Niraparib), widely used in the management of ovarian and related cancers. This blog provides an expert-level...
by mediaid pharmacy | Jan 27, 2026 | Blogs
Sunitinib 50 mg (Sunitix) is a widely prescribed targeted cancer therapy used in the treatment of several advanced and metastatic cancers. As a multi-targeted tyrosine kinase inhibitor (TKI), it plays a critical role in modern oncology by disrupting tumor blood supply...
by mediaid pharmacy | Jan 27, 2026 | Blogs
Crizotinib 250mg (Crizonix) is a targeted cancer therapy widely prescribed for specific types of non-small cell lung cancer (NSCLC). As a tyrosine kinase inhibitor (TKI), it plays a critical role in precision oncology by blocking abnormal proteins that drive cancer...
